Benitec Biopharma Inc.BNTC

Benitec Biopharma Inc. Segments Disclosure

10-KFiled Sep 22, 20252 min read
1
3
. Segment reporting
The Company’s operating segments are components of the Company for which separate discrete financial information is available and is evaluated by the Company’s chief operating decision maker (“CODM”), the
Chief Executive Officer
, in deciding how to allocate resources and assess performance. The Company’s CODM views the Company’s operations and manages its business as a single reportable segment with a
single
operating segment, which is the business of discovery and development of therapeutic agents in the treatment of genetic disorders.
While the Company has subsidiaries in several geographic regions, there are no standalone operations; rather, all R&D activities are supported by a single corporate team. The determination of a single reportable segment is consistent with the consolidated financial information available and regularly reviewed by the Company’s CODM. The Company manages R&D activities and operating expenses on a consolidated basis. 
The CODM uses comprehensive net loss in making decisions regarding resource allocation and evaluating financial performance, which is also reported on the consolidated statements of operations and comprehensive loss. The measure of segment assets is reported on the consolidated balance sheets as total assets.
The following table represents the potential format for reporting the results of the Company’s reportable segment for the year ending June 30, 2025:
 
(US$’000)
  
Fiscal Year Ended

June 30,
 
Operating Expenses
  
2025
 
  
2024
 
Royalties and license fees
  
$
— 
 
  
$
(108
) 
Research and development
  
 
18,332
 
  
 
15,609
 
General and administrative
  
 
23,433
 
  
 
6,989
 
Other segment items
  
 
(3,848
)
  
 
(739
)
  
 
 
 
  
 
 
 
Net loss
  
 
(37,917
)
  
 
(21,751
) 
Other segment items include foreign currency transaction gain (loss), interest income (expense), other expense, net gain on extinguishment of liabilities, and unrealized loss on investment

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.

Other Available Disclosures

Income TaxesRevenueEarnings Per SharePP&ELeasesCommitmentsNew Standards